Debate: Optimal neoadjuvant strategy in pancreatic cancer – Chemotherapy alone

Share it with your friends Like

Thanks! Share it with your friends!

Close

In this presentation from the 2017 Great Debates & Updates in GI Malignancies, Dr. Jordan Berlin argues that chemotherapy alone is the optimal neoadjuvant strategy for pancreatic cancer.

Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=GDUGI

© 2017 Imedex, LLC.

Comments

Write a comment

*